Mechanistic insight into immortal cells could speed clinical use

The mechanistic understanding of the relatively new technique for growing cells in culture indefinitely - known as conditional reprogramming - has been deciphered and reported in the February 25th issue of PLOS ONE . Researchers at Georgetown Lombardi Comprehensive Cancer Center say identifying the mechanisms of immortalization lays the groundwork for future clinical use of these cells.

http://ift.tt/1AL8uNv